OBJECTIVE: To determine whether an intervention focusing clinician attention on drug choice for hypertension treatment improves concordance between drug regimens and guidelines. STUDY DESIGN: Cluster-randomized controlled trial comparing an individualized intervention with a general guideline implementation in geographically diverse primary care clinics of a university-affiliated Department of Veterans Affairs healthcare system. METHODS:Participants were 36 attending physicians and nurse practitioners (16 in the general group and 20 in the individualized group), with findings based on 4500 hypertensive patients. A general guideline implementation for all clinicians, including education about guideline-based drug recommendations and goals for adequacy of blood pressure control, was compared with addition of a printed individualized advisory sent to clinicians at each patient visit, indicating whether or not the patient's antihypertensive drug regimen was guideline concordant. We measured change from baseline to end point in the proportion of clinicians' patients whose drug therapy was guideline concordant. RESULTS: The individualized intervention resulted in an improvement in guideline concordance more than twice that observed for the general intervention (10.9% vs 3.8%, t = 2.796, P = .008). Bootstrap analysis showed that being in the individualized group increased the odds of concordance 1.5-fold (P = .025). The proportion of patients with adequate blood pressure control increased within each study group; however, the difference between groups was not significant. CONCLUSION: An individualized advisory regarding drug therapy for hypertension given to the clinician at each patient visit was more effective in changing clinician prescribing behavior than implementation of a general guideline.
RCT Entities:
OBJECTIVE: To determine whether an intervention focusing clinician attention on drug choice for hypertension treatment improves concordance between drug regimens and guidelines. STUDY DESIGN: Cluster-randomized controlled trial comparing an individualized intervention with a general guideline implementation in geographically diverse primary care clinics of a university-affiliated Department of Veterans Affairs healthcare system. METHODS:Participants were 36 attending physicians and nurse practitioners (16 in the general group and 20 in the individualized group), with findings based on 4500 hypertensivepatients. A general guideline implementation for all clinicians, including education about guideline-based drug recommendations and goals for adequacy of blood pressure control, was compared with addition of a printed individualized advisory sent to clinicians at each patient visit, indicating whether or not the patient's antihypertensive drug regimen was guideline concordant. We measured change from baseline to end point in the proportion of clinicians' patients whose drug therapy was guideline concordant. RESULTS: The individualized intervention resulted in an improvement in guideline concordance more than twice that observed for the general intervention (10.9% vs 3.8%, t = 2.796, P = .008). Bootstrap analysis showed that being in the individualized group increased the odds of concordance 1.5-fold (P = .025). The proportion of patients with adequate blood pressure control increased within each study group; however, the difference between groups was not significant. CONCLUSION: An individualized advisory regarding drug therapy for hypertension given to the clinician at each patient visit was more effective in changing clinician prescribing behavior than implementation of a general guideline.
Authors: Gerd Flodgren; Elena Parmelli; Gaby Doumit; Melina Gattellari; Mary Ann O'Brien; Jeremy Grimshaw; Martin P Eccles Journal: Cochrane Database Syst Rev Date: 2011-08-10
Authors: Barry L Carter; William R Doucette; Carrie L Franciscus; Gail Ardery; Karen M Kluesner; Elizabeth A Chrischilles Journal: Pharmacotherapy Date: 2010-03 Impact factor: 4.705
Authors: Gbenga Ogedegbe; Jonathan N Tobin; Senaida Fernandez; Andrea Cassells; Marleny Diaz-Gloster; Chamanara Khalida; Thomas Pickering; Joseph E Schwartz Journal: Circulation Date: 2014-03-21 Impact factor: 29.690
Authors: Denise E Bonds; Patricia E Hogan; Alain G Bertoni; Haiying Chen; C Randall Clinch; Ann E Hiott; Erica L Rosenberger; David C Goff Journal: Am Heart J Date: 2008-11-20 Impact factor: 4.749
Authors: Michele Heisler; Timothy P Hofer; Mandi L Klamerus; Julie Schmittdiel; Joe Selby; Mary M Hogan; Hayden B Bosworth; Adam Tremblay; Eve A Kerr Journal: Trials Date: 2010-10-12 Impact factor: 2.279
Authors: L Kay Bartholomew; William C Cushman; Jeffrey A Cutler; Barry R Davis; Glenna Dawson; Paula T Einhorn; James F Graumlich; Linda B Piller; Sara Pressel; Edward J Roccella; Lara Simpson; Paul K Whelton; Angela Williard Journal: Clin Trials Date: 2009-07-08 Impact factor: 2.486
Authors: Monica Taljaard; Charles Weijer; Jeremy M Grimshaw; Judith Belle Brown; Ariella Binik; Robert Boruch; Jamie C Brehaut; Shazia H Chaudhry; Martin P Eccles; Andrew McRae; Raphael Saginur; Merrick Zwarenstein; Allan Donner Journal: Trials Date: 2009-07-28 Impact factor: 2.279